EuMotus

EuMotus, founded in 2015 at the Harvard Innovation Lab, develops markerless motion capture technology for clinical and athletic training applications.

Reviewed by 7wData

On this page

Profile

Markerless motion capture system that analyzes human movement for physical therapy and athletic training.

EuMotus, founded in 2015 at the Harvard Innovation Lab, develops markerless motion capture technology for clinical and athletic training applications. The company's flagship product, BodyWatch, is a portable system that analyzes human movement in 3D without markers or wearables, targeting physical therapy clinics and sports performance centers. EuMotus claims its technology reduces setup time to under a minute per assessment and delivers results in three minutes, addressing operational bottlenecks in traditional motion capture systems.

The company emphasizes improved patient retention (citing 20% increases for clients) and health outcomes through objective movement data. While specific revenue figures are undisclosed, EuMotus operates on a subscription model, aligning with its focus on ongoing customer value over one-time equipment sales. The company's peer-reviewed research foundation and single-camera approach differentiate it from lab-grade multi-camera systems, though this trade-off limits high-speed motion analysis capabilities.

Track EuMotus and 240+ vendors.

335k+ subscribers read the daily AI & data note. One email, both newsletters. Unsubscribe anytime.

Who buys this

  • Physical therapy clinics seeking objective movement data
  • Athletic training centers for performance optimization
  • Cash-based rehabilitation practices differentiating services
  • Sports teams implementing injury prevention programs

Strengths and what to watch

Strengths

  • Single-camera, markerless system reduces setup time to under one minute per assessment
  • Peer-reviewed research foundation for movement analysis algorithms
  • Subscription model aligns vendor incentives with ongoing clinical utility

Watch for

  • Trade-off between clinical speed and lab-grade accuracy limits high-speed motion analysis
  • Dependence on physical therapy clinic adoption in a competitive SaaS landscape
  • No disclosed venture funding or enterprise partnerships as of 2026

Key Information

Founded
2015

Frequently Asked Questions

What is EuMotus motion capture technology?

EuMotus develops markerless motion capture systems, like its flagship BodyWatch product, which analyze human movement in 3D without markers or wearables. Founded in 2015 at Harvard Innovation Lab, it targets physical therapy clinics and sports performance centers for clinical and athletic applications.

How does EuMotus benefit physical therapy clinics?

EuMotus reduces setup time to under a minute per assessment and delivers results in three minutes, addressing operational bottlenecks. Clinics report 20% increases in patient retention and improved health outcomes through objective movement data, making it valuable for cash-based rehabilitation practices.

What makes EuMotus different from traditional motion capture systems?

EuMotus uses a single-camera, markerless system, eliminating the need for markers or wearables. While faster and more portable than lab-grade multi-camera systems, it trades off high-speed motion analysis capabilities, focusing instead on clinical speed and ease of use.

Can EuMotus be used for athletic training?

Yes, EuMotus is used in athletic training centers and sports teams for performance optimization and injury prevention. Its portable, markerless system provides quick, objective movement analysis, helping athletes improve performance while reducing injury risks through data-driven insights.

What is EuMotus’ business model?

EuMotus operates on a subscription model, emphasizing ongoing customer value over one-time equipment sales. This aligns vendor incentives with clinical utility, ensuring continuous support and updates for users in physical therapy clinics and athletic training centers.

What are the limitations of EuMotus technology?

EuMotus sacrifices high-speed motion analysis capabilities for clinical speed and portability. Its single-camera approach, while efficient, cannot match the precision of lab-grade multi-camera systems, limiting its use in applications requiring ultra-high-speed motion capture.

Sources

  1. www.eumotus.com — Company origin, product claims, and operational metrics
  2. www.eumotus.com — Technical trade-offs and comparison to traditional motion capture
  3. www.eumotus.com — Patient retention statistics and business model rationale
  4. www.eumotus.com — Application use cases in physical therapy clinics